BIM

114.2

+0.79%↑

SRT3

229.5

+0.04%↑

ICAD

21.08

-1.31%↓

BIM

114.2

+0.79%↑

SRT3

229.5

+0.04%↑

ICAD

21.08

-1.31%↓

BIM

114.2

+0.79%↑

SRT3

229.5

+0.04%↑

ICAD

21.08

-1.31%↓

BIM

114.2

+0.79%↑

SRT3

229.5

+0.04%↑

ICAD

21.08

-1.31%↓

BIM

114.2

+0.79%↑

SRT3

229.5

+0.04%↑

ICAD

21.08

-1.31%↓

Search

Gerresheimer AG

Open

SectorHealthcare

54.3 2.94

Overview

Share price change

24h

Current

Min

52.35

Max

54.5

Key metrics

By Trading Economics

Income

-56M

-17M

Sales

-49M

520M

P/E

Sector Avg

22.741

57.333

EPS

0.46

Dividend yield

2.41

Profit margin

-3.363

Employees

13,632

EBITDA

-33M

84M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+83.02% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.41%

2.63%

Next Earnings

10 Jul 2025

Market Stats

By TradingEconomics

Market Cap

-40M

1.8B

Previous open

51.36

Previous close

54.3

Technical Score

By Trading Central

Confidence

Bullish Evidence

Gerresheimer AG Chart

Past performance is not a reliable indicator of future results.

Related News

4 Apr 2025, 10:15 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4 Apr 2025, 09:39 UTC

Acquisitions, Mergers, Takeovers

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

13 May 2024, 11:16 UTC

Top News

German Companies Bet on AI But Payoff Could Be Years Away -- Talking Markets

Peer Comparison

Price change

Gerresheimer AG Forecast

Price Target

By TipRanks

83.02% upside

12 Months Forecast

Average 98.1 EUR  83.02%

High 122.5 EUR

Low 84.5 EUR

Based on 12 Wall Street analysts offering 12 month price targets forGerresheimer AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

11

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

53.05 / 53.85Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Neutral Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.